The authors examined the relation of parental age at birth to the risk of prostate cancer among sons with the use of data from the Framingham Study. During 42 years of follow-up (1949-1993), 141 prostate cancer cases occurred in 2,164 men. All but six cases were confirmed by histologic report. The incidence rate of prostate cancer increased from 1.70 per 1,000 person-years among sons in the lowest quartile of paternal age (<27 years), to 2.00, 2.32, and 2.74 among those of each increased paternal age category (27-<32, 32-<38, and £38 years), respectively. After adjustment for age and other covariates, men in the second, third, and oldest quartiles of paternal age had 1.2, 1.3, and 1.7 times increased risk of prostate cancer compared with men in the youngest quartile (p for trend = 0.049). Further adjustment for maternal age did not change the relation materially. The association of older paternal age with risk of early-onset prostate cancer (<65 years) appeared stronger than that with late-onset disease (£65 years). No increased risk of prostate cancer was observed among subjects in the older maternal age category. The effect of increased paternal age on prostate cancer risk may operate through increased germ cell mutation rate or by mechanisms not yet defined. Am J Epidemiol 1999; 150:1208-12. cohort studies; maternal age; paternal age; prostatic neoplasms Prostate cancer is one of the most common cancers among men in the United States (1). The incidence rate increases with age, especially after age 65 years (2). Although numerous epidemiologic studies have examined both genetic and environmental factors in relation to the risk of prostate cancer, the specific causes of the disease remain poorly understood (3).
Prostate cancer is one of the most common cancers among men in the United States (1). The incidence rate increases with age, especially after age 65 years (2) . Although numerous epidemiologic studies have examined both genetic and environmental factors in relation to the risk of prostate cancer, the specific causes of the disease remain poorly understood (3) .
To date, most epidemiologic studies of risk factors for prostate cancer have focused on events that occurred in adult life, and few studies have assessed the potential effects of risk factors early in a man's life. Two studies (4, 5) evaluated the association between paternal age at birth and the risk of prostate cancer. The findings from these two studies, however, were conflicting. In a cross-sectional study, Henderson et al. (4) found that advanced paternal age at birth was not associated with an increased prevalence of prostate cancer, whereas in a case-control study, Janerich et al. (5) reported that a 10-year increase in paternal age was associated with a 45 percent decreased risk of prostate cancer. However, the number of prostate cancer cases in both studies were relatively small (65 cases for Henderson et al. (4) and 91 cases for Janerich et al. (5) ).
In the present analysis, we used data from the Framingham Study, a population-based cohort study, to examine the association between parental age at birth and the risk of prostate cancer. In addition, we explored whether the effect of parental age is more pronounced in early-or late-onset disease.
MATERIALS AND METHODS

The Framingham Study began in 1948 in
Framingham, Massachusetts, with the primary goal of evaluating risk factors for heart disease. The original cohort included 2,336 men (among 5,209 total participants), aged 29-62 years at the first examination. Subjects have been examined biennially since that time. At each examination, evaluation consists of a medical history and physical examination performed by a physician, and a series of laboratory and cardiovascular and other tests. Each subject's parental age at the time of his birth was determined from the following information: 1) the parents' years of birth, collected at the first Framingham examination; and 2) the date of birth of the study participant. Maternal and paternal ages at birth were calculated by subtracting the dates of birth of the mother and father from the date of birth of the study participant. Data on other covariates, including age, weight, height, number of years of education, and cigarette smoking were obtained from the first examination (1948) (1949) (1950) (1951) (1952) . Information on alcohol consumption was collected at the second biennial examination (1951) (1952) (1953) (1954) .
Methods used to identify cancer cases in the Framingham Study have been described in detail by Kreger et al. (6) . Briefly, cases were identified initially by self-report at each examination, surveillance of admissions to the only local hospital, and review of all death records. Participants who missed a regularly scheduled examination were contacted by telephone or mail to solicit information regarding medical events during the time interval since their last examination. For the non-respondents or subjects whose vital status was unknown, the National Death Index was searched to obtain vital status and cause of death. Pertinent medical records (pathology reports, operation notes, autopsies) were obtained from hospitals and physicians. Framingham records for each suspected cancer case were then reviewed to confirm the diagnosis and to determine the date of earliest diagnosis and details of histopathology. All cases were coded according to International Classification of Disease for Oncology (ICD-O) code 185 (7). All but six cases, which were diagnosed on the basis of clinical criteria, were confirmed by histologic report.
Person-years of follow-up for each man were computed as the amount of time from date of entry at examination 1 to the date of one of the following events: 1) prostate cancer diagnosis; 2) for subjects lost to follow-up, midpoint of interval between last contact date and date of the next scheduled examination; 3) death; or 4) the study closing date of December 31, 1993.
We classified subjects into quartile groups according to maternal age at birth (<24, 24-<28, 28-<33, >33) and the paternal age at birth (<27, 27-<32, 32^38, >38). Subjects with missing values for maternal or paternal ages were excluded from the corresponding analysis. Incidence rates for each maternal or paternal age group were calculated by dividing the number of events by person-years of follow-up. Age-adjusted incidence rates were obtained by direct standardization, using as a standard the distribution of age-specific person-years in the entire cohort.
We examined the relations of maternal and paternal age at birth to the risk of prostate cancer by computing rate ratios using Cox's proportional hazards models, with adjustment for age, height, body mass index, number of years of education, cigarette smoking, and alcohol consumption. We used age at diagnosis as the time variable in the multivariate analysis. To test for trend in risk, a continuous term for parental age was included in the multivariate model. Finally, to explore whether the parental age at birth has a different effect on the early-or late-onset prostate cancer, we divided the prostate cancer cases into two groups, i.e., cases diagnosed before age 65 years (early onset of disease), and cases diagnosed at or after age 65 years (late onset of disease). We compared the mean parental age at birth of noncases with early-and late-onset cases, and assessed the relation of parental age at birth to earlyor late-onset disease using Cox's proportional hazards model.
RESULTS
Of the 2,336 men who participated in the Framingham Study at examination 1, we excluded 172 subjects who had missing information on both maternal and paternal age at birth. Among the remaining 2,164 subjects, 141 developed prostate cancer during the course of follow-up. Table 1 shows the distribution of men's characteristics according to quartiles of paternal age at birth. There was no difference in age at entry into the study, height, body mass index, years of education, cigarette smoking, or alcohol consumption among subjects in different categories of paternal age. As shown in table 2, maternal age at birth was not associated with these factors either, except for number of years of education. Subjects born to young mothers tended to have had fewer years of education (p = 0.05).
The crude and age-adjusted incidence rates of prostate cancer according to parental age at birth are presented in table 3. The incidence rate of prostate cancer increased with increasing paternal age at birth, from 1.70 per 1,000 person-years among men with the younger paternal age (<27 years) to 2.00,2.32, and 2.74 with increasing paternal age category. Age-adjusted incidence rates were similar to the crude estimates. The incidence rate of prostate cancer increased in the third quartile of maternal age at birth, then leveled off. Table 4 gives the crude and multivariate adjusted rate ratios for prostate cancer according to parental age at birth. When adjustment was done for age and other covariates, men in the second, third, and highest quartiles of paternal age at birth had 1.2, 1.3, and 1.7 times increased risk compared with men in the lowest quartile (p for trend = 0.049). Adding maternal age at birth into the multivariate regression model did not change the relation materially, i.e., for each increased category of paternal age, the rate ratios were 1.0, 1.4, 1.5, and 1.9, respectively (p for trend = 0.047). In contrast to • SD, standard deviation. 11 inch = 2.54 cm. 11 oz = 29.6 ml.
paternal age, maternal age at birth had little or no effect on the risk of prostate cancer after controlling for paternal age and other factors (for each increased category of maternal age, the rate ratios were 1.0, 0.8, 0.9, and 0.8, respectively).
The relation of paternal age at birth to early-onset disease appeared to be stronger than that to late-onset disease. On average, subjects with early-onset (before age 65 years) disease (n = 15 cases) had fathers who were 4.5 years older at the time of the birth compared with noncases (p = 0.023), whereas cases with late onset of disease (119 cases) were only 1.0 year older than noncases (p = 0.18). The multivariate adjusted rate ratios of paternal age categories were 1.0, 1.2, 1.5, and 2.7 (p for trend = 0.162) for early-onset, and 1.0, 1.4, 1.4, and 1.7 for late-onset disease (p for trend = 0.092), respectively. No such relation, however, was observed for maternal age.
DISCUSSION
The results of the present study suggest that advanced paternal, but not maternal, age at the time of a child's birth is associated with an increased risk of prostate cancer in male offspring. The effect appears to be stronger for early-onset than late-onset disease.
The biologic mechanism for an association between paternal age at birth and prostate cancer among male offspring is not clear. In the late 1980s, Wilcox et al. (8) advocated using father's age to explore the role of germ cell mutation as a cause of human cancer. Several studies have found that advanced paternal, but not maternal, age at a child's birth is associated with some congenital anomalies or syndromes, such as achondroplasia (9), hydrocephaly (10, 11) , and Apert's syndrome (12) . Two studies also reported that older paternal age is associated with an increased risk of retinoblastoma (13) and Wilms' tumor (14) . Penrose (15) hypothesized that increased rate of gene mutation due to replication error as a consequence of continuous male germ cell division with aging may be an explanation for these observations. Thus, our findings that prostate cancer risk is more strongly associated with paternal than maternal age could result from the differences between men and women in their germ cell replication. Spermatogonia undergo continuous cell divisions throughout the male's adult life, while oocytes undergo only one cell division between puberty and fertilization (8) . Nevertheless, there may be other, as yet unknown, mechanisms which confer risk for prostate cancer with an advanced paternal age. While the relation of paternal age to the early-onset cases appears to be stronger than its relation to the lateonset cases, the number of early-onset cases is small, and the trend was not statistically significant.
Individuals with higher socioeconomic status tend to have children later, and offspring with higher socioeconomic status may have their prostate cancer detected earlier than those with lower socioeconomic status. In our study, however, number of years of education, an indicator of socioeconomic status, was not associated with paternal age at birth, and adjustment for the years of education did not change the observed association of paternal age with cancer risk. In addition, prevalence of other medical conditions may result in diagnostic bias because subjects with comorbidities are more likely to seek health care. The prevalence of several medical conditions at the baseline examination (coronary heart disease, congestive heart failure, cerebrovascular disease, hypertension, and diabetes mellitus) was similar among the subjects in the different parental age groups. Where differences were present, the prevalence of the disease was actually slightly higher among subjects with younger paternal age at birth than those with older paternal age. Thus, comorbidity from these diseases, that might lead to more frequent examinations, seems unlikely to account for the current findings. Nevertheless, we can not rule out potential diagnostic bias entirely, and future studies should adopt the best approaches available to address this issue. The cancer experience of the Framingham cohort closely approximates that of the Surveillance, Epidemiology, and End Results (SEER) population (6) . We believe that virtually all incident cases of clinically apparent prostate cancer were ascertained, and all but six cases were confirmed by histologic report.
Although the information on parental ages in our study was collected through interview, biased reporting of parental age is unlikely because parental age at birth was ascertained before prostate cancer was diagnosed, and the parental age at birth-chronic disease hypothesis was unknown at the interview. Random misclassification of parental age at birth, if it occurred, would have weakened an association. Information on family history of prostate cancer was not collected in this study. Therefore, we were unable to adjust for its potential confounding effect. Data on dietary animal fat intake were collected between 1966-1969 among 865 men by a single 24-hour dietary recall. The distribution of percent of total fat intake, calculated as a percent of total energy intake, was quite similar among the subjects with different paternal ages (percent of total fat intake was 38.8, 38.3, 38.9, and 39.4 percent for each quartile of paternal age at birth, respectively). Thus, fat intake does not appear to have a substantial confounding effect on the observed association. Nevertheless, because the etiology of prostate cancer is poorly understood and few risk factors have been identified so far, some unidentified risk factors may confound the observed relation.
In conclusion, the results from this population-based cohort study suggest that advanced paternal age at birth may be a risk factor for prostate cancer. Gene mutation due to replication error of germ cell with advanced age is a potential explanation.
